|
As drug and device companies develop new and innovative ways of promoting their products — such as targeting new markets, influencer marketing and using social media and reality television — it’s important to understand the regulatory priorities of the FDA and the FTC to avoid running afoul of those agencies. |
|
Top Trends in Drug and Device Advertising and Promotion takes a deep dive into six areas regulators give the most attention: |
-
Consistent Communication: Three factors that ensure communications are consistent with a product’s approved labeling
|
-
Direct-to-Consumer Advertising: Use of distracting visuals, competing superimposed images and lively music that can minimize the required presentation of risk information
-
Risk Disclosure: How much information needs to be presented and how
-
Payer Communications: Disseminating healthcare economic information, or HCEI, to payers postapproval
-
Preapproval Promotion: A new safe harbor for communicating information about investigational products to payers
-
Transparency: Making it clear that a communication is sponsored advertising
Order your copy of Top Trends in Drug and Device Advertising and Promotion: Enforcement Priorities for the FDA and FTC and know how to handle hot spots in advertising and promotion while avoiding warning letters and other enforcement actions.
Order Your Copy Today
PDF Edition
|
|
Available Format |
|
PDF Edition — $397
Table of Contents
- Introduction
- Promotional Hot Spots
- Ever-Shifting Enforcement Trends
- And More …
View the entire TOC
Who Will Benefit
- Executive suite
- Regulatory
- Compliance
- Legal counsel
- Strategic planning
- Marketing/sales
- Corporate communications/public affairs
Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.
Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.
|
|
|
